Enlivex Therapeutics (ENLV)
(Delayed Data from NSDQ)
$1.23 USD
-0.06 (-4.65%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.23 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/6/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | 12.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.81 |
Next Year | -0.59 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.18 | -0.81 | -0.59 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.22 | -0.18 | -0.81 | -0.59 |
High Estimate | -0.22 | -0.18 | -0.81 | -0.59 |
Low Estimate | -0.22 | -0.18 | -0.81 | -0.59 |
Year ago EPS | -0.37 | -0.32 | -1.56 | -0.81 |
Year over Year Growth Est. | 40.54% | 43.75% | 48.08% | 27.16% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.18 | -0.81 | -0.59 |
7 Days Ago | -0.22 | -0.18 | -0.81 | -0.59 |
30 Days Ago | -0.22 | -0.18 | -0.81 | -0.59 |
60 Days Ago | -0.22 | -0.18 | -0.81 | -0.59 |
90 Days Ago | -0.24 | -0.20 | -0.86 | -0.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.18 | -0.81 | -0.59 |
Zacks Consensus Estimate | -0.22 | -0.18 | -0.81 | -0.59 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.48 | -0.32 | -0.37 | NA |
Estimate | -0.25 | NA | -0.32 | -0.43 | NA |
Difference | 0.03 | NA | 0.00 | 0.06 | 0.03 |
Surprise | 12.00% | NA | 0.00% | 13.95% | 8.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more